ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41895
0.00%
Bitcoin
97,265.20
-0.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. MBX Biosciences Inc (MBX) Share Price

MBX Biosciences Inc

MBX Biosciences Inc (MBX)

My Foodie Box Ltd
Microbix Biosystems Inc
10.41
1.42
(15.80%)
Closed February 16 3:00PM
Delayed by 15 minutes
10.41
0.00
(0.00%)
After Hours: 4:14PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
10.41
Bid
10.07
Ask
10.80
Volume
242,972
9.03 Day's Range 10.49
8.631 52 Week Range 26.19
Market Cap
347.875M
Previous Close
8.99
Open
9.03
Last Trade
5
@
9.89
Last Trade Time
Financial Volume
US$ 2,389,918
VWAP
9.8362
Average Volume (3m)
298,601
Shares Outstanding
33,417,418
Dividend Yield
-
PE Ratio
-10.68
Earnings Per Share (EPS)
-0.97
Revenue
-
Net Profit
-32.56M

About MBX Biosciences Inc

MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time... MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. We are advancing a pipeline of novel candidates for endocrine and metabolic disorders. Our lead product candidate, MBX 2109, is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism, or HP. We designed MBX 2109 to treat the underlying pathophysiology of HP by providing a continuous, infusion-like exposure to parathyroid hormone, or PTH, with convenient once-weekly administration. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.mbxbio.com.
Headquarters
Wilmington, Delaware, USA
Founded
-
MBX Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MBX. The last closing price for MBX Biosciences was US$8.99. Over the last year, MBX Biosciences shares have traded in a share price range of US$ 8.631 to US$ 26.19.

MBX Biosciences currently has 33,417,418 shares outstanding. The market capitalization of MBX Biosciences is US$300.42 million. MBX Biosciences has a price to earnings ratio (PE ratio) of -10.68.

Ask ADVFN Intelligence (AI)

MBX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 05 2025
MBX (15.80%)

Form 8-K - Current report
Edgar (US Regulatory)
January 07 2025
MBX (15.80%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 07 2024
MBX (15.80%)

Form 8-K - Current report
Edgar (US Regulatory)
November 07 2024
MBX (15.80%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-14.74201474212.2113.42528.63140304210.47779251CS
4-0.15-1.4204545454510.5614.238.63132826610.79417448CS
12-6.34-37.850746268716.7524.198.63129860115.75385738CS
26-12.59-54.73913043482326.198.63122679717.79760496CS
52-12.59-54.73913043482326.198.63122679717.79760496CS
156-12.59-54.73913043482326.198.63122679717.79760496CS
260-12.59-54.73913043482326.198.63122679717.79760496CS

MBX - Frequently Asked Questions (FAQ)

What is the current MBX Biosciences share price?
The current share price of MBX Biosciences is US$ 10.41
How many MBX Biosciences shares are in issue?
MBX Biosciences has 33,417,418 shares in issue
What is the market cap of MBX Biosciences?
The market capitalisation of MBX Biosciences is USD 300.42M
What is the 1 year trading range for MBX Biosciences share price?
MBX Biosciences has traded in the range of US$ 8.631 to US$ 26.19 during the past year
What is the PE ratio of MBX Biosciences?
The price to earnings ratio of MBX Biosciences is -10.68
What is the reporting currency for MBX Biosciences?
MBX Biosciences reports financial results in USD
What is the latest annual profit for MBX Biosciences?
The latest annual profit of MBX Biosciences is USD -32.56M
What is the registered address of MBX Biosciences?
The registered address for MBX Biosciences is THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the MBX Biosciences website address?
The website address for MBX Biosciences is www.mbxbio.com.
Which industry sector does MBX Biosciences operate in?
MBX Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
US$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
189.56M

Discussion

View Full Feed
KIPK KIPK 11 minutes ago
JONDOEUK,
This thing is more air than oxygen .. Just like your NVCR...

You know who is coming?? 👀
NVCR
mrfence mrfence 12 minutes ago
You've put yourself on ignore, lol!
FNMA
KIPK KIPK 14 minutes ago
Try harder jondoeuk. If as you colluded......

>>>>>>>Finally, NWBO is a shitco scam >>>>

Why are you so afraid of NWBO....

I AM SURE YOU KNOW WHY!!
NWBO
SilkRoad SilkRoad 17 minutes ago
Drop in and go using existing infrastructure. That was the drumbeat we heard many moons ago. But every step of the way they have to seemingly build a new facility, bring in and/or modify equipment, add a lab, add testing, get a license, open an office, and bring in outside experts. I think you ar
KBLB
Peter J Peter J 19 minutes ago
no matter what desperate attempts they try in order to attract buyers there is something called common sense that most investors use to stay away from a disaster like ERHC.
Come on badog, get real please: talking solely about your and ssc's motives for posting here can hardly qualify as tryin
ERHE
chereb19 chereb19 26 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/16/kprkvScreenshot_2025-02-16-11-06-05-307_com.twitter.android-edit.jpg
RDGL
Peter J Peter J 29 minutes ago
Badog, read the 6th post, how relevant, again!

https://www.lse.co.uk/profiles/supercooper/
I also don't post on boards where I have no holdings. Why on earth are you posting on the Tlw board if you have no interest Long or Short. Trying to make yourself feel good by denigrating
ERHE
sharkey1 sharkey1 30 minutes ago
Hypothetical press release:

Tuesday AM.
Elite is in talks with XYZ company, no name yet, and they are huge with billions
in the market cap, and there stock is worth 30 bucks a share.
And theres a leak as to who it is.
Elites stock will shoot up fast to me
XYZ
baltimorebullet baltimorebullet 34 minutes ago
One wildcard no one is mentioning is other indebted developed countries may follow the U.S. and begin to reduce their government employee headcounts.
That could slow down the EMA among many other things.
AVXL
sharkey1 sharkey1 35 minutes ago
Can’t sleep, waiting for the M and A news that could come Tuesday morning.
It’s a 3 day weekend, they could be working on anything. Instead of merger Monday
could be merger Tuesday.
ELTP
chereb19 chereb19 39 minutes ago
Glad you're on board @I-Blow

Vivos Inc, a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in humans and animals, is pleased to report several significant outcomes after its signature product, IsoPet®, was used to
RDGL
EZ2 EZ2 39 minutes ago
17-12-22-23 ..... Gl !!
EZ2 EZ2 45 minutes ago
Hi Red ! 
cojoboy cojoboy 47 minutes ago
Hey...you said it..not me.????...but..I would invest in a Death Star..🤔🤔🤔🤔
PHIL
Dumb&dumber4long Dumb&dumber4long 51 minutes ago
Taking a small position is more likely, when technicals are not fully aligned (to one’s standards, which I did for FOMO.
However, a more substantial position warrants patience.
If it results in averaging up a little, then be it.
If it has not bottomed yet, then it’ll be averagin
TNXP
10thMountain 10thMountain 54 minutes ago
FDCT Tweet with chart..Only 33 million float. It’s bouncing off the 50 day ma. MACD is curly up. The last time I pounded the table, it went from low pennies to .16! The next big move is in the making….

https://x.com/randylus/status/1890790544235704558?s=46
FDCT
lovethatgreen lovethatgreen 1 hour ago
According to the last q in September last shares issued in 2023 was in dec and then there were no new shares issued until June of 2024. All of those shares would have been included in the OS . So if old 2022 debt is being sold why is the OS getting larger unless they they are issuing new shares fo
AFFU
SkeBallLarry SkeBallLarry 1 hour ago
Trump on DOGE: “We literally started off with >

14 or 15 young geniuses.
Now we have 100 young geniuses.
And what’s happened…
People are calling up from all over the country wanting to help Elon Musk.”
https://x.com/unusual_whales/status/18907783424016672
SkeBallLarry SkeBallLarry 1 hour ago
Trump on DOGE: “We literally started off with >

14 or 15 young geniuses.
Now we have 100 young geniuses.
And what’s happened…
People are calling up from all over the country wanting to help Elon Musk.”
https://x.com/unusual_whales/status/18907783424016672
SkeBallLarry SkeBallLarry 1 hour ago
DOGE scores big court win, allowed access data on 3 federal agencies

Musk hailed the decision by reposting its news on X with the caption: 'LFG'

https://www.foxnews.com/politics/doge-scores-big-court-win-allowed-access-data-3-federal-agencies
SkeBallLarry SkeBallLarry 1 hour ago
DOGE scores big court win, allowed access data on 3 federal agencies

Musk hailed the decision by reposting its news on X with the caption: 'LFG'

https://www.foxnews.com/politics/doge-scores-big-court-win-allowed-access-data-3-federal-agencies

Your Recent History

NASDAQ
MBX
MBX Biosciences
LSE
0A21
Sabre
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads